Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Dr Alpesh Mistry is a fellowship-trained Consultant Radiologist at Rutherford Cancer Centre North West. He currently holds NHS posts at the Royal Liverpool and Broadgreen University Hospitals. Dr Alpesh Mistry completed his radiology training in Norwich and a musculoskeletal imaging fellowship at the University of Toronto in 2013. His interests are musculoskeletal ultrasound and bone and soft tissue tumours.
He specialises in the treatment of Musculoskeletal trauma and sports injuries to the spine and soft tissue in the body. He also treats soft tissue Sarcomas and is trained in musculoskeletal ultrasound procedures.
Royal College of Radiologists
British Society of Skeletal Radiology
European Society of Skeletal Radiology
Royal Society of North America
Honorary clinical lecturer at the University of Liverpool
Dr Alpesh Mistry does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Alpesh Mistry does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Alpesh Mistry does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.